BrainStorm Cell Therapeutics
BCLI
#10383
Rank
โ‚ฌ5.71 M
Marketcap
0,52ย โ‚ฌ
Share price
12.96%
Change (1 day)
-70.03%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -โ‚ฌ9.77 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ9.87 Million, an increase over its 2023 earnings that were of -โ‚ฌ14.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ9.77 Million-1.02%
2024 -โ‚ฌ9.87 Million-32.39%
2023 -โ‚ฌ14.59 Million-29.18%
2022 -โ‚ฌ20.6 Million-0.74%
2021 -โ‚ฌ20.76 Million-23.12%
2020 -โ‚ฌ27 Million36.8%
2019 -โ‚ฌ19.74 Million66.71%
2018 -โ‚ฌ11.84 Million181.66%
2017 -โ‚ฌ4.21 Million-0.6%
2016 -โ‚ฌ4.23 Million-41.31%
2015 -โ‚ฌ7.21 Million-8.22%
2014 -โ‚ฌ7.85 Million89.74%
2013 -โ‚ฌ4.14 Million42.27%
2012 -โ‚ฌ2.91 Million-12.45%
2011 -โ‚ฌ3.33 Million63.04%
2010 -โ‚ฌ2.04 Million35.52%
2009 -โ‚ฌ1.51 Million-48.99%
2008 -โ‚ฌ2.95 Million-44.39%
2007 -โ‚ฌ5.3 Million
2005 -โ‚ฌ2.75 Million-91.44%
2004 -โ‚ฌ32.06 Million94007.62%
2003 -โ‚ฌ0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
โ‚ฌ1.61 B-17,654.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ8.38 B-91,248.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-โ‚ฌ0.68 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-โ‚ฌ0.64 Billion 6,832.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ17.53 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-โ‚ฌ0.22 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA